Identification of sequences downstream of the primer binding site that are important for efficient replication of human immunodeficiency virus type 1

Journal of Virology

Volumn 71, Issue 8, 1997, Pages 6003-6010

  Li, Xuguang ^a,b   Liang, Chen ^a   Quan, Yudong ^a   Chandok, Ravi ^b   Laughrea, Michael ^a,b   Parniak, Michael A ^a,b   Kleiman, Lawrence ^a,b   Wainberg, Mark A ^a,b,c  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DACTINOMYCIN; MESSENGER RNA; VIRUS DNA;

ARTICLE; BINDING SITE; DELETION MUTANT; DNA FLANKING REGION; GENETIC TRANSFECTION; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; SEQUENCE ANALYSIS; STOP CODON; VIRUS GENOME; VIRUS REPLICATION;

EID: 0030848171     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.8.6003-6010.1997     Document Type: Article

References (60)

1. Trp primer is required for efficient initiation of reverse transcription. J. Virol. 66:2464-2472.
2. Aldovini, A., and R. Young. 1990. Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus. J. Virol. 64:1920-1926.
3. Arts, E. J., and M. A. Wainberg. 1994. Preferential incorporation of nucleoside analogs after template switching during human immunodeficiency virus reverse transcription. Antimicrob. Agents Chemother. 38:1008-1016.
4. Lys.3 as primers in an endogenous HIV-1 in vitro reverse transcription/template switching reaction. J. Biol. Chem. 269:14672-14680.
5. Lys.3 interactions inhibiting primer utilization by retroviral reverse transcriptions. Proc. Natl. Acad. Sci. USA 93:10063-10068.
6. Baudin, F., R. Marquet, C. Isel, J.-L. Darlix, B. Ehresmann, and C. Ehresmann. 1993. Functional sites in the 5′ region of HIV-1 RNA form defined structural domains. J. Mol. Biol. 229:382-397.
7. Berkhout, B., R. H. Silverman, and K. T. Jeang. 1989. Tat transactivates the human immunodeficiency virus through a nascent RNA target. Cell 59:273-282.
8. Berkhout, B., and L. Schoneveld. 1993. Secondary structure of the HIV-2 leader RNA comprising the tRNA-primer binding site. Nucleic Acids Res. 21:1171-1178.
9. Berlioz, C., and J.-L. Darlix. 1995. An internal ribosome entry mechanism promotes translation of murine leukemia virus gag polyprotein procursors. J. Virol. 69:2214-2222.
10. Boulerice, F., S. Bour, R. Geleziunas, A. Lvovich, and M. A. Wainberg. 1990. High frequency of isolation of defective human immunodeficiency virus type 1 and heterogeneity of viral gene expression in clones of infected U937 cells. J. Virol. 64:1745-1755.
11. Clavel, F., and J. M. Orenstein. 1990. A mutation of human immunodeficiency viruses with reduced RNA packaging and abnormal particle morphology. J. Virol. 64:5230-5234.
12. Cobrinik, D., A. Aiyar, Z. Ge, M. Katzman, H. Huang, and J. Leis. 1991. Overlapping U5 sequence elements are required for efficient integration and initiation of reverse transcription. J. Virol. 65:3864-3872.
13. Cobrinik, D., L. Soskey, and J. Leis. 1988: A retroviral RNA secondary structure required for efficient initiation of reverse transcription. J. Virol. 62:3622-3630.
14. Cullen, B. R. 1991. Regulation of HIV-1 gene expression. FASEB J. 5:2361-2368.
15. Darlix, J.-L., C. Gubas, M.-T. Nugeyre, F. Clavel, and F. Barre-Sinoussi. 1990. Cis elements and trans-acting factors involved in the RNA dimerization of HIV-1. J. Mol. Biol. 216:689-699.
16. Lys. J. Virol. 69:3090-3097.
17. El Kharronbi, A., and M. A. Martin. 1996. cis-Acting sequences located downstream of the human immunodeficiency virus type 1 promotor affect its chromatin structure and transcriptional activity. Mol. Cell. Biol. 16:2958-2966.
18. El Kharronbi, A., and E. Verdin. 1994. Protein-DNA interactions with DNase-I hypersensitive sites located downstream of the HIV-1 promotor. J. Biol. Chem. 269:19916-19924.
19. Felber, B. K., M. Hadzopoulou-Cladaras, C. Cladaras, T. Copeland, and G. N. Pavlakis. 1989. Rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA. Proc. Natl. Acad. Sci. USA 86:1495-1499.
20. Gilboa, E., S. W. Mitra, S. P. Goff, and D. Baltimore. 1979. A detailed model of reverse transcription and tests of crucial aspects. Cell 18:93-100.
21. Harrich, D., C. Ulich, and R. B. Gaynor. 1996. A critical role for the TAR element in promoting efficient human immunodeficiency virus type 1 reverse transcription. J. Virol. 70:4017-4027.
22. Harrison, G. P., and A. M. L. Lever. 1992. The human immunodeficiency virus type 1 packaging signal and major splice donor region have a conserved stable secondary structure. J. Virol. 66:4144-4153.
23. Haseltine, W. A. 1991. Molecular biology of HIV-1. FASEB J. 5:2349-2360.
24. Lys.3 (template/primer) complex. J. Mol. Biol. 247:236-250.
25. Lys.3. EMBO J. 15:917-924.
26. Lys.3 modulate primer/template loop-loop interactions in the initiation complex of HIV-1 reverse transcription. J. Biol. Chem. 269:1388-1993.
27. Jiang, M., J. Mak, A. Ladha, E. Cohen, M. Klein, B. Rovinski, and L. Kleiman. 1993. Identification of tRNAs incorporated into wild-type and mutant human immunodeficiency virus type 1. J. Virol. 67:3246-3253.
28. Kang, S. M., J. K. Wakefield, and C. D. Morrow. 1996. Mutations in both the U5 region and the primer-binding site influence the selection of the tRNA used for the initiation of HIV-1 reverse transcription. Virology. 222:401-414.
29. Met. J. Virol. 71:207-217.
30. Karpel, R. L., L. Henderson, and L. E. Oroszlan. 1987. Interactions of retroviral structural proteins with single stranded nucleic acids. J. Biol. Chem. 262:4961-4967.
31. Khan, R., and D. Giedroc. 1992. Recombinant human immunodeficiency virus type 1 nucleocapsid protein unwinds tRNA. J. Biol. Chem. 267:6689-6695.
32. Kim, H. J., K. Lee, and J. J. O'Rear. 1994. A short sequence upstream of the 5′ major splicing donor is important for encapsidation of human immunodeficiency virus type 1 genomic RNA. Virology 198:336-340.
33. Glu as primer in an in vitro utilization assay. Proc. Natl. Acad. Sci. USA 89:4652-4656.
34. Leis, J., A. Ashok, and D. Cobrinik. 1993. Regulation of initiation of reverse transcription of retroviruses, p. 33-47. In A. M. Skalka and S. P. Goff (ed.), Reverse transcriptase. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
35. Lever, A. M. L., H. Gottlinger, W. Haseltine, and J. Sodroski. 1989. Identification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virions. J. Virol. 63:4085-4087.
36. Li, X., J. Mak, E. J. Arts, Z. Gu, L. Kleiman, M. A. Wainberg, and M. A. Parniak. 1994. Effects of alterations of primer binding site sequences on human immunodeficiency virus type 1 replication. J. Virol. 68:6198-6206.
37. Lys in vitro. J. Virol. 70:4996-5004.
38. Lys.3: role of reverse transcriptase. Trends Biochem. Sci. 19:114-118.
39. Lori, F., F. Veronese, A. L. De Vico, P. Lusso, M. S. Reitz, and R. C. Gallo. 1992. Viral DNA carried by human immunodeficiency virus type 1 virions. J. Virol. 66:5067-5074.
40. Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
41. Marquet, R., F. Baudin, C. Gabus, J.-L. Darlix, M. Mongel, C. Ehresmann, and B. Ehresmann. 1991. Dimerization of HIV-1 RNA: stimulation by cations and possible mechanism. Nucleic Acids Res. 19:2349-2357.
42. Miele, G., A. Mouland, G. P. Harrison, E. Cohen, and A. M. L. Lever. 1996. The human immunodeficiency virus type 1 5′ packaging signal structure affects translation but does not function as an internal ribosome entry site structure. J. Virol. 70:944-951.
43. Muesing, M. A., D. H. Smith, and D. J. Capon. 1987. Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein. Cell 48:691-701.
44. Murphy, J. E., and S. P. Goff. 1989. Construction and analysis of deletion mutations in the U5 region of Moloney murine leukemia virus: effects on RNA packaging and reverse transcription. J. Virol. 63:319-327.
45. Paillart, J.-C., R. Marquet, E. Scripkin, B. Ehresmann, and C. Ehresmann. 1994. Mutational analysis of the bipartite dimer linkage structure of HIV-1 genomic RNA. J. Biol. Chem. 269:27486-27493.
46. Panganiban, A., and H. Temin. 1983. The terminal nucleotides of retrovirus DNA are required for integration but not for virus production. Nature (London) 306:155-160.
47. Picard, V., E. Ersdal-Badju, A. Lu, and S. C. Bock. 1994. A rapid and efficient one-tube PCR-based mutagenesis technique using Pfu DNA polymerase. Nucleic Acids Res. 22:2587-2591.
48. Prats, A. C., L. Sarih, C. Gabus, S. Litvak, G. Keith, and J. L. Darlix. 1988. Small finger protein of avian and murine retroviruses has nucleic acid annealing activity and positions the replication primer tRNA onto genomic RNA. EMBO J. 7:1777-1783.
49. Ratner, L., W. Haseltine, R. Patarca, K. J. Livak, B. Starcich, S. F. Josephs, E. R. Doran, J. A. Rafalski, E. A. Whitehorn, K. Baumeister, L. Ivanoff, S. R. Petteway, Jr., M. L. Pearson, J. A. Lautenberger, T. S. Papas, J. Ghrayeb, N. T. Chang, R. C. Gallo, and F. Wong-Staal. 1985. Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature (London) 313:277-284.
50. Lys primer-binding site of human immunodeficiency virus type 1 identify essential regions for reverse transcription. J. Virol. 65:4555-4564.
51. Lys.3. Nucleic Acids Res. 24:509-514.
52. Skripkin, E., J.-C. Pallart, R. Marquet, B. Ehresmann, and C. Ehresmann. 1994. Identification of the primary site of HIV-1 RNA dimerization in vitro. Proc. Natl. Acad. Sci. USA 91:4945-4949.
53. Soudeyns, H., R. Geleziunas, G. Shyamala, J. Hiscott, and M. A. Wainberg. 1993. Identification of a novel glucocorticoid response element within the genome of the human immunodeficiency virus type 1. Virology 194:758-768.
54. Trono, D. 1992. Partial reverse transcripts in virions from human immunodeficiency and murine leukemia viruses. J. Virol. 66:4893-4900.
55. Van Lint, C., J. Ghysdael, P. Paras, Jr., A., Burney, and E. Verdin. 1994. A transcriptional regulatory element is associated with a nuclease-hypersensitive site in the pol gene of human immunodeficiency virus type 1. J. Virol. 68:2632-2648.
56. Vicenzi, E., D. S. Dimitrov, A. Engelman, T.-S. Migone, D. F. J. Purcell, J. Leonard, G. Englund, and M. A. Martin. 1994. An integration-defective U5 deletion mutant of human immunodeficiency virus type 1 reverts by eliminating additional long terminal repeat sequences. J. Virol. 68:7879-7890.
57. His. J. Virol. 70:966-975.
58. Lys. J. Virol. 69:6021-6029.
59. Whitcomb, J. M., B. A. Ortiz-Conde, and S. H. Hughes. 1995. Replication of avian leukosis viruses with mutations at the primer binding site: use of alternate tRNAs as primer. J. Virol. 69:6228-6238.
60. Zack, J. A., S. J. Arrigo, S. R. Weitsman, A. S. Go, A. Haislip, and I. S. Y. Chen. 1990. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell. 61:213-222.